Spyre Therapeutics, Inc. Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Spyre Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • Spyre Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -160 %, a 108% decline year-over-year.
  • Spyre Therapeutics, Inc. annual Return On Equity for 2023 was 576 %.
  • Spyre Therapeutics, Inc. annual Return On Equity for 2022 was -127 %, a 107% decline from 2021.
  • Spyre Therapeutics, Inc. annual Return On Equity for 2021 was -61.4 %, a 10.6% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 576 +704 Jan 1, 2023 Dec 31, 2023
2022 -127 -65.8 -107% Jan 1, 2022 Dec 31, 2022
2021 -61.4 +7.29 +10.6% Jan 1, 2021 Dec 31, 2021
2020 -68.7 +19.3 +21.9% Jan 1, 2020 Dec 31, 2020
2019 -88 -16.6 -23.2% Jan 1, 2019 Dec 31, 2019
2018 -71.4 -23.1 -47.9% Jan 1, 2018 Dec 31, 2018
2017 -48.3 +0.35 +0.72% Jan 1, 2017 Dec 31, 2017
2016 -48.6 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.